Roche Diagnostics cobas™ liat Influenza A/B + RSV Multiplex Assay

Description

Automated multiplex real-time RT-PCR assay for the rapid in vitro qualitative detection and discrimination of Influenza A and B virus and RSV RNA in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.

• No patient age restrictions for test
• Testing accuracy with RT-PCR technology
• Definitive results with no need for interpretation or confirmation
• Fast, easy operation
• Three easy steps
• Results in 20 minutes

Specifications

• Accuracy: Influenza A: Positive Agreement 98.4%, Negative Agreement 96.5%. Influenza B: Positive Agreement 97.9%, Negative Agreement 99.4%. RSV: Positive Agreement 97.8%, Negative Agreement 98.4%
• Certifications/Compliance: None
• Content And Storage: 36°F to 46°F
• Control Sets: Controls purchases separately (FCAT# 23312203)
• CPT Code: 87631
• CE Marker: No
• Clia Complexity: Waived
• Detectable Analytes: Influenza A and B, Respiratory Syncytial Virus (RSV) RNA
• Format: Case (Kit)
• Sample Type: Nasopharyngeal
• Sensitivity: Influenza A: Positive Agreement 98.4%, Negative Agreement 96.5%. Influenza B: Positive Agreement 97.9%, Negative Agreement 99.4%. RSV: Positive Agreement 97.8%, Negative Agreement 98.4%
• Type: Nucleic Acid RT-PCR Influenza A, Influenza B, RSV
• Packaging Type: Case (kit)
• Quantity: 20 Tests/Cs. (Kit)
• Specificity: Negative Agreement: Influenza A 96.5%; Influenza B 99.4%; RSV 98.4%
• Test Time: 20 min.